Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ICOSLG anticorps (AA 23-149)

ICOSLG Reactivité: Humain WB, ELISA, IHC, FACS, IF, Coat, IHC (f) Hôte: Souris Monoclonal ICOSL-3111 unconjugated
N° du produit ABIN6937473
  • Antigène Voir toutes ICOSLG Anticorps
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Épitope
    • 8
    • 7
    • 7
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 23-149
    Reactivité
    • 68
    • 13
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 26
    • 6
    • 1
    Souris
    Clonalité
    • 40
    • 35
    • 1
    Monoclonal
    Conjugué
    • 45
    • 8
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ICOSLG est non-conjugé
    Application
    • 43
    • 35
    • 25
    • 15
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (IF), Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    This MAb recognizes a protein of 36 kDa, identified as ICOS-L. It is a ligand for the ICOS receptor that initiates T and B cell proliferation and cytokine secretion. ICOS-L interactions play an essential role in T cell-dependent B cell activation in peripheral lymphoid organs such as spleen and lymph nodes. ICOS-L protein is present in myeloid leukocytes, and by Northern blot there are 2.4, 3.0, and 7.0 kb transcripts in brain, heart, kidney, and liver, with lower expression in colon and thymus, and a 1.1 kb transcript in leukocytes. Tumor necrosis factor alpha (TNF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) enhance its expression. LPS-induced up-regulation of ICOS-L is dependent on the MyD88-dependent signaling pathway.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant fragment of human ICOSLG (B7RP-1) protein (around aa 23-149) (exact sequence is proprietary)
    Clone
    ICOSL-3111
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product ICOSLG Anticorps primaire
  • Indications d'application

    Known_Application: ELISA (For coating, order antibody without BSA), Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: U937, HL60, HuT78 and HUVEC lysates (WB). Human tonsil tissue (IHC).

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Autre désignation
    ICOSLG (ICOSLG Produits)
    Synonymes
    anticorps ICOSLG, anticorps AU044799, anticorps B7-H2, anticorps B7RP-1, anticorps B7h, anticorps BG071784, anticorps GI50, anticorps GL50, anticorps GL50-B, anticorps ICOS-L, anticorps Icoslg, anticorps LICOS, anticorps Ly115l, anticorps mKIAA0653, anticorps B7H2, anticorps B7RP1, anticorps CD275, anticorps ICOSL, anticorps Icosl, anticorps RGD1562791, anticorps inducible T-cell costimulator ligand, anticorps icos ligand, anticorps inducible T-cell co-stimulator ligand, anticorps ICOSLG, anticorps Icosl, anticorps Icoslg
    Sujet
    B7 homolog 2 (B7H2), B7 like protein Gl50, B7 related protein 1 (B7RP1), CD275, CD275 antigen, GL50, ICOS LG, ICOS ligand (ICOSL), Inducible T cell co stimulator ligand, LICOS, Transmembrane protein B7 H2 ICOS ligand,ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target)
    Cellular localisation: Cell Surface and Cytoplasmic
    Poids moléculaire
    36kDa
    ID gène
    23308, 14155
    UniProt
    O75144
    Pathways
    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Vous êtes ici:
Support technique